Publicaciones en las que colabora con Alberto Ortiz Arduan (15)

1996

  1. Interferon-inducible protein-10 is highly expressed in rats with experimental nephrosis

    American Journal of Pathology, Vol. 148, Núm. 1, pp. 301-311

  2. Urinary excretion of platelet-activating factor in human and experimental nephrosis

    Nephrology Dialysis Transplantation, Vol. 11, Núm. 2, pp. 282-286

1995

  1. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis

    Kidney International, Vol. 48, Núm. 6, pp. 1778-1791

  2. Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor-alpha (TNF-α), platelet-activating factor (PAF) and FN in proliferative glomerulonephritis

    Clinical and Experimental Immunology, Vol. 101, Núm. 2, pp. 334-340

  3. Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis.

    Advances in nephrology from the Necker Hospital, Vol. 24, pp. 53-77

1994

  1. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats

    Laboratory Investigation, Vol. 70, Núm. 4, pp. 449-459

  2. The potential role of inflammatory and fibrogenic cytokines in the glomerular diseases

    Journal of Lipid Mediators and Cell Signalling, Vol. 9, Núm. 1, pp. 55-74

1993

  1. Role of tumor necrosis factor-α in the pathogenesis of glomerular diseases

    Kidney International, Supplement

  2. The intercrine superfamily and renal disease

    Kidney International, Supplement

1992

  1. LA PARTICIPACION DE CITOQUINAS Y MATRIZ EXTRACELULAR EN LA PROGRESION DEL DANO RENAL

    Nefrologia, Vol. 12, Núm. SUPPL. 5, pp. 22-32

1991

  1. Involvement of lipid mediators in the pathogenesis of experimental nephrosis in rats: Its pharmacological modulation

    Renal Failure, Vol. 13, Núm. 2-3, pp. 95-101

1990

  1. Evidence suggesting a role for platelet-activating factor (PAF) in experimental nephrotic syndrome

    International Journal of Tissue Reactions, Vol. 12, Núm. 4, pp. 213-220

  2. Rational bases for the use of cyclosporin A in the nephrotic syndrome

    Nefrologia, Vol. 10, Núm. SUPPL. 5, pp. 16-24

  3. The participation of platelet-activating factor and cytokines in the pathogenesis of glomerular damage

    Revista clínica española, Vol. 187, Núm. 3, pp. 137-143

1987

  1. Role of platelet-activating factor in adriamycin-induced nephropathy in rats

    European Journal of Pharmacology, Vol. 138, Núm. 1, pp. 119-123